Your session is about to expire
← Back to Search
Yoga vs Running for Metabolic Health (TrainMeUpMN Trial)
N/A
Waitlist Available
Led By Lisa S. Chow, MD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
For overweight or obese subjects: Insulin resistant based on screening oral glucose tolerance testing, BMI 25 to 40 kg/m2 inclusive, stable weight for at least 3 months (± 5 lbs.), sedentary status (self-report < 30 minutes/week regular exercise)
All subjects must be 18 to 40 years of age and capable of giving informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how different types of exercise affect the body's ability to handle sugar in people with different body types.
Who is the study for?
This trial is for people aged 18-40, with a BMI of 25 to 40 kg/m2. It's open to those who are overweight or obese and insulin resistant but generally healthy. Participants should be sedentary (exercising less than 30 minutes per week) or lean and physically active (3-5 aerobic sessions per week), with stable weight for the past three months.
What is being tested?
The study compares fat and sugar metabolism in individuals before and after they complete either a supervised treadmill running program or a yoga training program. The goal is to understand how these activities affect insulin resistance, which can lead to type 2 diabetes.
What are the potential side effects?
While not explicitly listed, potential side effects may include typical exercise-related risks such as muscle strain, fatigue, joint pain from the running program; yoga might cause muscle soreness or stretching-related injuries.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am overweight or obese, have insulin resistance, a stable weight, and exercise less than 30 minutes a week.
Select...
I am between 18 and 40 years old and can make my own medical decisions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after exercise program (exercise program will take 16 weeks, expected average for evaluation will be 20 weeks)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Differences in insulin sensitivity between groups
Secondary study objectives
Differences in fitness level between groups
Other study objectives
Differences in body composition between groups
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Obese or OverweightExperimental Treatment2 Interventions
Running Program Yoga Program
Group II: Lean TrainedActive Control1 Intervention
Metabolic control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Yoga Program
2022
N/A
~120
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Supervised aerobic and yoga training improve insulin sensitivity in lean trained subjects by enhancing the body's ability to utilize fat and sugar. This is achieved through increased mitochondrial activity and changes in muscle composition, which facilitate better glucose uptake and utilization.
These mechanisms are crucial for maintaining metabolic health and preventing insulin resistance, a precursor to type 2 diabetes.
Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity.Effects of Polarized Training on Cardiometabolic Risk Factors in Young Overweight and Obese Women: A Randomized-Controlled Trial.
Exercise training improves mitochondrial respiration and is associated with an altered intramuscular phospholipid signature in women with obesity.Effects of Polarized Training on Cardiometabolic Risk Factors in Young Overweight and Obese Women: A Randomized-Controlled Trial.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,423 Previous Clinical Trials
1,619,721 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,439 Previous Clinical Trials
4,324,760 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,810 Previous Clinical Trials
8,159,568 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are slim and physically active.This applies to everyone who is considering participating in the study.Your body mass index (BMI) falls between 25 and 40, which means you may be overweight or obese.You are stable weight for at least 3 months (± 5 lbs.).I am able to understand and agree to the study's procedures and risks.I exercise less than 30 minutes a week.I am overweight or obese, have insulin resistance, a stable weight, and exercise less than 30 minutes a week.I am between 18 and 40 years old.I am overweight or obese.You exercise vigorously for at least 3-5 sessions per week.You exercise 3-5 times a week with aerobic activities.I exercise 3-5 times a week and have normal blood sugar levels.I am between 18 and 40 years old and can make my own medical decisions.
Research Study Groups:
This trial has the following groups:- Group 1: Obese or Overweight
- Group 2: Lean Trained
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger